Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neonatology · Leiner's disease

What to Expect in the NICU for Leiner's Disease

At a Glance

A NICU stay for Leiner's disease focuses on intensive skin protection, preventing severe infections, and providing nutritional support. Babies typically receive care in humidified incubators, intravenous nutrition (TPN) to counter diarrhea, and fresh frozen plasma to correct immune deficiencies.

Seeing your baby admitted to the Neonatal Intensive Care Unit (NICU) can be frightening, especially when dealing with a rare condition like Leiner’s disease. During this hospitalization, your baby’s care team will focus on protecting their fragile skin, providing intense nutritional support, preventing infection, and managing their comfort. Because Leiner’s disease causes severe, full-body skin peeling and weakens the immune system, the NICU environment and the equipment used will look different from standard newborn care.

The Physical Environment: Monitors, Isolation, and Touch

Babies with Leiner’s disease (also known as erythroderma desquamativum) lack an intact outer skin layer, which normally acts as a barrier against germs, helps retain body heat, and prevents fluid loss [1]. To compensate for this, you can expect the following in the NICU:

  • Incubator Care: Your baby will likely be placed in a specialized incubator that provides a carefully controlled, warm, and humidified environment. This helps stabilize their body temperature and limits the amount of water evaporating through their compromised skin [2][3].
  • Specialized Monitoring: Standard sticky monitor pads can tear a baby’s already damaged skin. To prevent skin stripping, nurses will use non-adhesive securement methods, specialized barrier wraps, or specially designed probes to track your baby’s heart rate, breathing, and oxygen levels [4][5].
  • Strict Isolation Protocols: Because Leiner’s disease involves a defect in the immune system (often a dysfunction in a specific immune protein called complement C5), infants are highly susceptible to severe bacterial infections [6][7]. The NICU will employ strict “barrier nursing” and infection control strategies [8]. This means anyone interacting with your baby—including you—may need to wear gowns, gloves, and masks.
  • Touch and Pain Management: The severe skin peeling can be incredibly uncomfortable. The care team closely monitors for signs of pain and will provide appropriate pain-relieving medications to keep your baby comfortable. Because their skin is so delicate, traditional holding might be delayed initially to allow the skin to heal [5]. However, the nurses will teach you safe, modified ways to comfort your baby, such as gentle “containment holds” (placing still, steady hands on the baby without stroking or rubbing). Please do not bring baby lotions from home; the NICU must use specific, sterile emollients to prevent introducing bacteria to the fragile skin.

Tubes and Lines: Delivering Essential Treatments

To minimize pain and reduce the risk of infection, the medical team will avoid repeatedly poking your baby for blood draws and IVs [9][10]. Instead, they will use more permanent lines to deliver crucial, life-saving therapies:

  • Central Venous Catheters: Doctors will typically place a central line or a PICC line (Peripherally Inserted Central Catheter) using ultrasound guidance [11][12]. This is a thin, soft tube inserted into a larger vein that can remain in place for weeks. It allows the team to deliver medications, draw blood, and provide nutrition without causing further trauma to the skin.
  • Total Parenteral Nutrition (TPN): Because Leiner’s disease causes chronic diarrhea and massive loss of proteins and electrolytes through the skin, babies struggle to absorb nutrients and gain weight [13][1]. TPN is an intravenous liquid mixture of proteins, fats, sugars, and vitamins given directly through the central line. If you plan to provide breastmilk, the team will likely encourage you to pump and freeze it for when your baby’s gut is healed enough to process standard feeds.
  • Fresh Frozen Plasma (FFP): To correct the underlying immune defect, doctors may administer infusions of fresh frozen plasma [14]. This plasma contains the vital complement C5 proteins your baby’s body is missing, significantly improving their ability to fight off bacterial and fungal infections [7]. Because FFP is a donor blood product, the medical team will discuss the specific benefits and risks with you before asking for your formal consent to proceed.

Timeline for Stabilization

While every baby’s journey is unique, the NICU hospitalization generally follows a phased approach:

  1. Acute Stabilization (Days to Weeks): The immediate focus is on correcting dangerous fluid and electrolyte imbalances (dehydration), providing pain relief, and aggressively treating any existing infections with intravenous antibiotics.
  2. Nutritional Recovery: As the IV nutrition (TPN) takes effect and the chronic diarrhea begins to resolve, the team will slowly introduce specialized enteral feeds (breastmilk or formula given through a feeding tube into the stomach).
  3. Skin and Immune Healing: With consistent plasma treatments and intensive topical skin care, the extreme skin peeling will gradually improve. As the skin heals, the nurses will teach you how to safely apply the specialized, sterile emollients so you can actively participate in your baby’s daily care.

Discharge planning usually begins when your baby can maintain their body temperature in an open crib, steadily gain weight on regular feedings, and show significant skin healing.

Common questions in this guide

Why does my baby with Leiner's disease need fresh frozen plasma (FFP)?
Fresh frozen plasma contains essential complement C5 proteins that are missing in infants with Leiner's disease. Receiving this donor plasma significantly improves your baby's immune system, allowing them to fight off severe bacterial and fungal infections.
How will the NICU team protect my baby's peeling skin?
The medical team will use non-adhesive monitors and specially designed wraps instead of sticky tape to prevent skin tearing. Your baby will also be kept in a humidified incubator to retain body heat and moisture, while nurses apply specialized sterile emollients.
When will I be able to hold my baby?
Traditional holding may be delayed at first because your baby's skin is extremely fragile and prone to tearing. The nursing staff will teach you modified ways to provide comfort, such as gentle containment holds, until the skin heals enough for safe, regular holding.
How will my baby receive nutrition if they have chronic diarrhea?
Doctors will likely use a central line or PICC line to deliver Total Parenteral Nutrition (TPN), which is an intravenous liquid mixture of proteins, fats, and vitamins. As your baby's gut heals and diarrhea improves, standard feeds like breastmilk or formula will be slowly introduced.
Why are doctors and nurses wearing full protective gear around my baby?
Because babies with Leiner's disease have compromised immune systems, they are highly susceptible to severe infections. The NICU uses strict barrier nursing protocols, meaning anyone interacting with your baby must wear protective gear like gowns, gloves, and masks.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the current plan for my baby's nutritional support, and should I be pumping breastmilk to freeze for when their digestive tract is ready?
  2. 2.How are you assessing and managing my baby's pain and discomfort today?
  3. 3.What are the specific criteria or milestones my baby needs to reach before we can safely hold them?
  4. 4.When fresh frozen plasma (FFP) is recommended, what are the specific benefits and risks for my baby's current condition?
  5. 5.How can I safely participate in my baby's daily care and skin treatments while maintaining strict infection control?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome.

    Zelieskova M, Banovcin P, Kozar M, et al.

    Pediatric dermatology 2020; (37(6)):1202-1204 doi:10.1111/pde.14318.

    PMID: 32767583
  2. 2

    Skin Physiology of the Neonate and Infant: Clinical Implications.

    Oranges T, Dini V, Romanelli M

    Advances in wound care 2015; (4(10)):587-595 doi:10.1089/wound.2015.0642.

    PMID: 26487977
  3. 3

    Association between Congenital Anomalies and Late-Onset Bacterial Infections in Neonates Admitted to Neonatal Intensive Care Units in Australia and New Zealand: A Population-Based Cohort Study.

    Chughtai AA, Spotswood N, Strunk T, et al.

    Neonatology 2025; (122(1)):95-105 doi:10.1159/000540276.

    PMID: 39299217
  4. 4

    The effect of the use of sterile transparent film dressing on the catheter dwell time and the development of catheter-related complications in newborns: Randomized clinical trial.

    Çalıkuşu İncekar M, Yıldız S, Gül Y, Uzunhan O

    Enfermeria clinica 2025; (35(3)):102147 doi:10.1016/j.enfcle.2025.102147.

    PMID: 39961505
  5. 5

    Cyanoacrylate Securement in Neonatal PICC Use: A 4-Year Observational Study.

    van Rens M, Nimeri AMA, Spencer TR, et al.

    Advances in neonatal care : official journal of the National Association of Neonatal Nurses 2022; (22(3)):270-279 doi:10.1097/ANC.0000000000000963.

    PMID: 34743117
  6. 6

    Description and phenotype of a novel C5 gene mutation and a novel combination: family report and literature review.

    Lizama-Muñoz A, Gutiérrez-Bautista JF, Bernal M, López-Nevot MÁ

    Frontiers in immunology 2025; (16()):1605903 doi:10.3389/fimmu.2025.1605903.

    PMID: 40692790
  7. 7

    Invasive Meningococcal Disease Unraveling a Novel Mutation in the C5 Gene in a Portuguese Family.

    Marujo F, Costa LC, Duarte R, et al.

    The Pediatric infectious disease journal 2019; (38(4)):416-418 doi:10.1097/INF.0000000000002149.

    PMID: 30882736
  8. 8

    Adverse consequences of neonatal antibiotic exposure.

    Cotten CM

    Current opinion in pediatrics 2016; (28(2)):141-9 doi:10.1097/MOP.0000000000000338.

    PMID: 26886785
  9. 9

    Peripherally inserted central catheters in extremely preterm infants: Placement success rates and complications.

    Gavelli V, Wackernagel D

    Acta paediatrica (Oslo, Norway : 1992) 2022; (111(3)):554-556 doi:10.1111/apa.16181.

    PMID: 34757656
  10. 10

    A Retrospective Analysis of the Clinical Effectiveness of Supraclavicular, Ultrasound-guided Brachiocephalic Vein Cannulations in Preterm Infants.

    Breschan C, Graf G, Jost R, et al.

    Anesthesiology 2018; (128(1)):38-43 doi:10.1097/ALN.0000000000001871.

    PMID: 28906265
  11. 11

    Comparison of Risks from Central Venous Catheters and Peripheral Intravenous Lines among Term Neonates in a Tertiary Care Hospital, India.

    Ratchagame V, Prabakaran V

    Journal of caring sciences 2021; (10(2)):57-61 doi:10.34172/jcs.2021.012.

    PMID: 34222113
  12. 12

    A narrative review on tip navigation and tip location of central venous access devices in the neonate: Intracavitary ECG or real time ultrasound?

    Natile M, Ancora G, D'Andrea V, et al.

    The journal of vascular access 2025; (26(4)):1115-1122 doi:10.1177/11297298241259247.

    PMID: 39090995
  13. 13

    Bullous Pemphigoid Mimicking Cellulitis.

    Ivyanskiy I, Dave D, Dweik A, et al.

    Journal of investigative medicine high impact case reports 2021; (9()):23247096211008585 doi:10.1177/23247096211008585.

    PMID: 33847152
  14. 14

    Systematic screening for primary immunodeficiencies in patients hospitalized for severe infection in pediatric intensive care unit.

    Deguet A, Vigue MG, Lozano C, et al.

    Scientific reports 2025; (15(1)):22170 doi:10.1038/s41598-025-02870-7.

    PMID: 40593888

This page explains general NICU procedures for infants with Leiner's disease for educational purposes only. Always consult your neonatologist for specific details regarding your baby's care, treatments, and condition.

Get notified when new evidence is published on Erythroderma desquamativum.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.